EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$1.12
+0.00 (+0.00%)
As of Feb 8, 2:29 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.48M 2.49M 2.71M
Net Income -380,025 -467,867 -467,071
EPS
Profit Margin -15.3% -18.8% -17.2%
Rev Growth +22.9% +23.1% -7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 990.1K 775.0K 843.9K
Total Equity 3.39M 3.01M 3.06M
D/E Ratio 0.29 0.26 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -552,767 -558,041 -685,415
Free Cash Flow -221,579 -328,689 -323,480